Gene · 5771
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
| Adipokines in glucose and lipid metabolism. | Adipocyte | 2023 | 37077042 | PubTator, text mining | PubMed |
| The clinical and experimental treatment of Juvenile Idiopathic Arthritis. | Clin Exp Immunol | 2023 | 37074076 | PubTator, text mining | PubMed |
| Novel strategies for cancer immunotherapy: counter-immunoediting therapy. | J Hematol Oncol | 2023 | 37055849 | PubTator, text mining | PubMed |
| Predicted the structural diversity and electronic properties of Pt-N compounds under high pressure. | J Phys Condens Matter | 2023 | 37054735 | PubTator, text mining | PubMed |
| The Battlefield of Chemotherapy in Pediatric Cancers. | Cancers (Basel) | 2023 | 37046624 | PubTator, text mining | PubMed |
| PTPN2 Is a Critical Regulator of Ileal Paneth Cell Viability and Function in Mice. | Cell Mol Gastroenterol Hepatol | 2023 | 37030630 | PubTator, text mining | PubMed |
| Exploring the pharmacological and adverse reaction mechanism of a drug by network pharmacology strategy: Using colchicine to treat Behcet syndrome as an example. | Medicine (Baltimore) | 2023 | 37026906 | PubTator, text mining | PubMed |
| A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology. | Ther Adv Med Oncol | 2023 | 37025260 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2023 | 37008925 | PubTator, text mining | PubMed |
| Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. | Cell Rep | 2023 | 37000627 | PubTator, text mining | PubMed |
| Spermidine Ameliorates Colitis via Induction of Anti-Inflammatory Macrophages and Prevention of Intestinal Dysbiosis. | J Crohns Colitis | 2023 | 36995738 | PubTator, text mining | PubMed |
| Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death. | Diabetologia | 2023 | 36988639 | PubTator, text mining | PubMed |
| The EGFR phosphatase RPTPγ is a redox-regulated suppressor of promigratory signaling. | EMBO J | 2023 | 36988334 | PubTator, text mining | PubMed |
| MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma. | Diagnostics (Basel) | 2023 | 36980512 | PubTator, text mining | PubMed |
| Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy. | Angew Chem Int Ed Engl | 2023 | 36973833 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatases: Mighty oaks from little acorns grow. | IUBMB Life | 2023 | 36971473 | PubTator, text mining | PubMed |
| Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy. | Cancer Res Commun | 2023 | 36968224 | PubTator, text mining | PubMed |
| Isosteviol derivatives as protein tyrosine Phosphatase-1B inhibitors: Synthesis, biological evaluation and molecular docking. | Bioorg Med Chem | 2023 | 36963270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5771/papers?page=14